Not So Innocent: Thrombocytopenia After One Dose of Rifampicin

Not So Innocent: Thrombocytopenia After One Dose of Rifampicin

Saved in:

Bibliographic Details
Main Authors:	Tarana NAGIYEVA, Meltem Işıkgöz TAŞBAKAN, Hüsnü PULLUKÇU, Oğuz Reşat SİPAHİ, Tansu YAMAZHAN
Format:	Article
Language:	English
Published:	Galenos Publishing House 2017-12-01
Series:	Mediterranean Journal of Infection, Microbes and Antimicrobials
Subjects:	Rifampicin thrombocytopenia adverse effect cat bite rifampin
Online Access:	http://www.mjima.org/pdf.php?&id=95
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of the Gene Xpert Mycobacterium tuberculosis/resistance to rifampicin assay in rapid diagnosis of tuberculosis and identification of rifampin resistance in tuberculous patients
by: Amal H.G. Hamed, et al.
Published: (2025-01-01)

Rifampin mediated decapsulation and enhanced bacterial clearance: a new mechanism of rifamycinsResearch in context
by: Gi Young Lee, et al.
Published: (2025-07-01)

Is Urinary Tract Infection Different in Elderly and Adults Aged Under 65 Years? Ege University Experience
by: Hüseyin Aytaç ERDEM, et al.
Published: (2016-12-01)

Evaluation of Hepatosplenomegaly and Liver Function Tests in 102 Brucellosis Cases
by: Serhat UYSAL, et al.
Published: (2014-12-01)

GENE MUTATION PATTERNS OF RIFAMPICIN IN MULTIDRUG RESISTANT MYCOBACTERIUM TUBERCULOSIS COMPLEX STRAINS
by: Esra Yıldırım Servi, et al.
Published: (2022-03-01)

Effect of Ursodeoxycholic Acid Alone Verses Ursodeoxycholic Acid and Rifampicin in Obstetric Cholestasis
by: Ayesha Amjad, et al.
Published: (2025-07-01)

Background of Infectious Diseases Consultations: Dealing With Side Effects
by: Sukru Dirik, et al.
Published: (2024-12-01)

Clinical Profiles of Multidrug-Resistant and Rifampicin-Monoresistant Tuberculosis in Korea, 2018–2021: A Nationwide Cross-Sectional Study
by: Jinsoo Min, et al.
Published: (2025-01-01)

Evaluation of usefulness of single-strand conformation polymorphism method for rapid detection of rifampicin-resistant mycobacterium tuberculosis
by: Tešić Jelena, et al.
Published: (2004-01-01)

Pathological Changes of Rifampicin Toxicity on Some Organs in Rats
by: Dalia Amer Khudhair
Published: (2025-04-01)

Effect of rifampicin on the kidney of albino rats
by: DE Peters, et al.
Published: (2013-07-01)

Drug-Induced Black Hairy Tongue: A Case Report
by: Hayati DEMİRASLAN
Published: (2013-12-01)

Dual versus triple therapy for uncomplicated brucellosis: A retrospective cohort study
by: Rawan O Al-Madfaa, et al.
Published: (2020-12-01)

Embelin mitigates hepatotoxicity induced by isoniazid and rifampicin in rats
by: O. F. Mosa
Published: (2024-06-01)

Insight into rifampicin resistance behind discordant mutations in RpoB of Mycobacterium tuberculosis: A molecular dynamics simulations study
by: Muhammad Tahir Khan, et al.
Published: (2025-07-01)

THE MOLECULAR GENETIC FEATURES OF RIFAMPICIN RESISTANCE AND THE PREVALENCE OF rpoB GENE MUTATIONS IN THE SARATOV REGION
by: T. Yu. Salina, et al.
Published: (2014-04-01)

Synergistic combinations of novel polymyxins and rifampicin with improved eradication of colistin-resistant Pseudomonas aeruginosa biofilms
by: Johan Storm Jørgensen, et al.
Published: (2024-12-01)

High-Dose Rifampicin for 3 Months after Culture Conversion for Drug-Susceptible Pulmonary Tuberculosis
by: Nakwon Kwak, et al.
Published: (2025-01-01)

Understanding Rifampicin Resistance in Tuberculosis through a Computational Approach
by: Satish Kumar, et al.
Published: (2014-12-01)

Parametric Population Pharmacokinetics Model Repository of Rifampicin: Model-Informed Individualized Therapy
by: Ju G, et al.
Published: (2025-04-01)

Efavirenz Plasma Concentrations and HIV Viral Load in HIV/AIDS-tuberculosis Infection Patients Treated with Rifampicin
by: Nina Mariana, et al.
Published: (2016-09-01)

Efavirenz Plasma Concentrations and HIV Viral Load in HIV/AIDS-tuberculosis Infection Patients Treated with Rifampicin
by: Nina Mariana, et al.
Published: (2016-09-01)

Rectal Administration of Rifampicin and Isoniazid Suppositories: An Alternative Approach for the Treatment of Tuberculosis in a Patient with Multiple Comorbidities
by: Ioana Munteanu, et al.
Published: (2025-05-01)

Investigating thrombocytopenia in Meropenem-treated patients: a cross-sectional observational study
by: Ahmed E. Altyar, et al.
Published: (2025-07-01)

Biological Cost of Helicobacter pylori Rifampicin Resistance
by: K. T. Momynaliev, et al.
Published: (2020-05-01)

Bacterial and viral etiology in hospitalized community acquired pneumonia with molecular methods and clinical evaluation
by: Derya Çağlayan Serin, et al.
Published: (2014-04-01)

Clinical and Laboratory Analysis of Children Who Follow Up with Thrombocytopenia: A Retrospective Study
by: Yasemin Denkboy Öngen, et al.
Published: (2025-04-01)

Combined in vivo and silico assessment of melatonin’s protective effects on rifampicin-induced liver damage in rats
by: Khaled Abo-EL-Sooud, et al.
Published: (2025-08-01)

Lethal Risk Factors in Patients with Rifampicin Resistant Tuberculosis according to Federal Register of Tuberculosis Cases
by: I. A. Vasilyeva, et al.
Published: (2024-12-01)

Genetic Determinants of Rifampicin Resistance of Mycobacterium tuberculosis not Included in the Russian Molecular Genetic Test Systems
by: E. A. Mazurina, et al.
Published: (2023-07-01)

Prevalence of mutations in Mycobacterium tuberculosis genes coding resistance to isoniazid and rifampicin in tuberculosis patients from different age groups
by: T. Yu. Salina, et al.
Published: (2019-05-01)

Effect of sepiolite on the physical properties and swelling behavior of rifampicin-loaded nanocomposite hydrogels
Published: (2009-08-01)

The Protective Effect of Betaine on Inhibition of Rifampin-Induced Liver Damage in Rats
by: P Peiravi, et al.
Published: (2024-03-01)

RFLP clusters of rifampicin resistant and susceptible Mycobacterium tuberculosis strains in Western province of Sri Lanka
by: Chamila Priyangani Adikaram, et al.
Published: (2017-09-01)

Role of GeneXpert MTB/RIF assay for the diagnosis of cervical lymph node tuberculosis and rifampicin resistance
by: Sahjid Mukhida, et al.
Published: (2022-01-01)

In Vitro and Ex Vivo Evaluation of Rifampicin Cytotoxicity in Human Skin Models
by: Marcel Nani Leite, et al.
Published: (2025-07-01)

Guanethidine Enhances the Antibacterial Activity of Rifampicin Against Multidrug-Resistant Bacteria
by: Xiaoou Zhao, et al.
Published: (2024-10-01)

Discordance in genotypic and phenotypic drug susceptibility results: time to reconsider critical concentration of rifampicin
by: Arti Shrivas, et al.
Published: (2025-03-01)

Primary Closure in Animal Bites to Hands: A 7-year Retrospective Cohort Study
by: Matija Mandic, et al.
Published: (2025-01-01)

Formulation, Characterisation, and Biocompatibility Assessment of Rifampicin-Loaded Poly(d,l-lactide-co-glycolide) Composites for Local Treatment of Orthopaedic and Wound Infections
by: Mitali Singhal, et al.
Published: (2024-11-01)